Anticoagulation in COVID-19: DDI Perspective.

Khiali, Sajad; Entezari-Maleki, Taher

Khiali, Sajad; Entezari-Maleki, Taher.

Khiali S; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Entezari-Maleki T; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Clin Appl Thromb Hemost ; 26: 1076029620959457, 2020.

Article in English | MEDLINE | ID: covidwho-772056

Subject(s)

Anticoagulants/therapeutic use; Betacoronavirus; Coronavirus Infections/drug therapy; Drug Interactions; Pneumonia, Viral/drug therapy; Anticoagulants/adverse effects; Blood Coagulation/drug effects; COVID-19; Coronavirus Infections/complications; Humans; Pandemics; Pneumonia, Viral/complications; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Drug Interactions / Betacoronavirus / Anticoagulants Topics: Long Covid Limits: Humans Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2020 Document Type: Article Affiliation country: 1076029620959457

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google